VioQuest Pharmaceuticals, Inc.
VOQP · OTC
6/30/2008 | 3/31/2008 | 12/31/2007 | 9/30/2007 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $2 | $2 | $3 |
| Operating Income | $1 | $2 | $3 | $3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | -$2 | -$3 | -$3 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $1 | $1 | $0 |
| Net Income | -$1 | -$3 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS | -0.23 | -0.63 | -0.631 | -0.63 |
| % Growth | 63.5% | 0.1% | -0.1% | – |
| EPS Diluted | -0.23 | -0.63 | -0.631 | -0.63 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 5 |
| Weighted Avg Shares Out Dil | 5 | 5 | 5 | 5 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $1 | $1 |
| EBITDA | -$1 | -$2 | -$1 | -$2 |
| % Margin | – | – | – | – |